22 related articles for article (PubMed ID: 14682385)
1. Mice primed with swainsonine are protected against doxorubicin-induced lethality.
Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; Griffin WM; Sridhar R
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1089-99. PubMed ID: 14682391
[TBL] [Abstract][Full Text] [Related]
2. Limits of stimulation of proliferation and differentiation of bone marrow cells of mice treated with swainsonine.
Oredipe OA; Furbert-Harris PM; Laniyan I; Griffin WM; Sridhar R
Int Immunopharmacol; 2003 Oct; 3(10-11):1537-47. PubMed ID: 12946451
[TBL] [Abstract][Full Text] [Related]
3. Enhanced proliferation of functionally competent bone marrow cells in different strains of mice treated with swainsonine.
Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; White SL; Olden K; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
Int Immunopharmacol; 2003 Mar; 3(3):445-55. PubMed ID: 12639822
[TBL] [Abstract][Full Text] [Related]
4. Antarth, a polyherbal preparation protects against the doxorubicin-induced toxicity without compromising its Antineoplastic activity.
Jagetia GC; Reddy TK; Malagi KJ; Nayak BS; Naidu MB; Ravikiran PB; Kamath SU; Shetty PC; Reddy DS
Phytother Res; 2005 Sep; 19(9):772-8. PubMed ID: 16220569
[TBL] [Abstract][Full Text] [Related]
5. Swainsonine stimulates bone marrow cell proliferation and differentiation in different strains of inbred mice.
Oredipe OA; Furbert-Harris PM; Green WR; White SL; Olden K; Laniyan I; Parish-Gause D; Vaughn T; Griffin WM; Sridhar R
Pharmacol Res; 2003 Jan; 47(1):69-74. PubMed ID: 12526864
[TBL] [Abstract][Full Text] [Related]
6. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
7. Swainsonine: a new antineoplastic immunomodulator.
Mohla S; Humphries MJ; White SL; Matsumoto K; Newton SA; Sampson CC; Bowen D; Olden K
J Natl Med Assoc; 1989 Oct; 81(10):1049-56. PubMed ID: 2509720
[TBL] [Abstract][Full Text] [Related]
8. The potential importance of swainsonine in therapy for cancers and immunology.
Olden K; Breton P; Grzegorzewski K; Yasuda Y; Gause BL; Oredipe OA; Newton SA; White SL
Pharmacol Ther; 1991; 50(3):285-90. PubMed ID: 1754603
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of swainsonine and doxorubicin attenuates doxorubicin-induced lethality in mice.
Oredipe OA; Furbert-Harris PM; Laniyan I; Green WR; Griffin WM; Sridhar R
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1037-48. PubMed ID: 14682385
[TBL] [Abstract][Full Text] [Related]
10. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.
Robert J
Cell Biol Toxicol; 2007 Jan; 23(1):27-37. PubMed ID: 17041747
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
